Key facts
- Notable investors include PharmStars, Orbit Ventures (Venture Capital).
- Status: Privately Held (backing).
- ·The complete investor list — 2 names
- ·Watchlist + deal alerts for OmicsBank
- ·The full record, as it builds
Funding rounds
No funding rounds for OmicsBank are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About OmicsBank
Developer of a multi-omics and clinical data platform designed for research, drug development, and clinical trials. The company's platform provides structured electronic health records, genomic and proteomic datasets, biospecimen samples, and annotated imaging data, enabling biotech researchers and pharmaceutical companies to access regulatory-grade data for precision medicine, clinical studies, and AI model development.
- Sector
- Healthcare
- HQ
- New York, NY, United States
- Website
- omicsbank.com/
- Ownership
- Privately Held (backing)
OmicsBank doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in OmicsBank shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on OmicsBank in its N-PORT filings yet. We sweep new filings monthly.